J&J to buy surgical robotics company for $3.4bn

Johnson & Johnson (J&J) has announced plans to strengthen its robotics programme with the addition of Silicon Valley-based Auris Health to its business.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Surgical device maker hit with $10m damages in stapler patent dispute

20 October 2022 Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.

Americas

J&J to acquire Verily stake in Verb Surgical

23 December 2019 Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily.

Big Pharma

Johnson & Johnson braces for Q3 sales dip as generics bite

18 July 2019 Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.

More on this story

Americas

Surgical device maker hit with $10m damages in stapler patent dispute

20 October 2022 Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.

Americas

J&J to acquire Verily stake in Verb Surgical

23 December 2019 Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily.

Big Pharma

Johnson & Johnson braces for Q3 sales dip as generics bite

18 July 2019 Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.

More on this story

Americas

Surgical device maker hit with $10m damages in stapler patent dispute

20 October 2022 Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.

Americas

J&J to acquire Verily stake in Verb Surgical

23 December 2019 Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily.

Big Pharma

Johnson & Johnson braces for Q3 sales dip as generics bite

18 July 2019 Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.